http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2449298-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0046 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91c35d2f600b661c7a6e8068216c8d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7eb065434f5b37a8690ca2bfaf39849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d7a558eabc20edd1abba60a0e5e42ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5538639c13ca0bacd9006de66cf2d550 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06eab8df5a709d63cb24a22c7f3c5067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ac270d79b40b5a7b238424fe8c8fa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f98ba598f1394d254386dec72045f1 |
| publicationDate | 2014-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2449298-T3 |
| titleOfInvention | Process for the preparation of complex catalysts of ruthenium metathesis |
| abstract | A process for the preparation of compounds of formula I ** Formula ** in which the dotted line means the existence of a bond or no link; L has the meaning of a neutral ligand selected from in which R7 and R8 independently of each other are C1-6 alkyl, aryl, C2-6 alkenyl or 1-adamantyl and R9a-d are independently of each other hydrogen, C1- alkyl 6, C2-6 alkenyl or aryl, or R9b and R9c or R9a and R9 taken together form a bridge - (CH2) 4-; or R9a and R9d in formula 2s have the meaning of halogen; Ra1, Ra2 and Ra3 independently of each other are C1-6 alkyl, C3-8 cycloalkyl, aryl, heteroaryl or Ra1 and Ra2 or Ra2 and Ra3 or Ra3 and Ra3 taken together form a 1.5 cyclooctyl bridge group; X1 and X2 independently of each other are anionic ligands; Y1 is hydrogen, C 1-6 alkyl, C 3-8 cycloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 alkoxy, C 2-6 alkenyloxy, C 2-6 alkynyloxy, aryloxy, C 1-6 alkylcarbonyl, C 1-6 thioalkyl , aryl, thioaryl, C1-6 alkylsulfonyl, C1-6 alkylsulfinyl; a, b, c and independently of each other have the meaning of hydrogen, C1-6 alkyl, halogen-C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2 alkynyloxy -6, C1-6 alkylcarbonyl, aryl, hydroxy, aryloxy, nitro, C1-6 alkoxycarbonyl, amino, C1-6 monoalkyl or C1-6 dialkylamino, halogen, thio, C1-6 thioalkyl, thioaryl, C1-6 alkylsulfonyl, alkylsulfinyl C1-6, arylsulfonyl, SO3H, C1-6 alkylcarbonylamino, arylcarbonylamino, alkyl, C1-6 alkylsulfonylamino, arylsulfonylamino, halogen-C1-6 alkylsulfonylamino, SO3-C1-6 alkyl or OSi (C1-6 alkyl) 3 and SO2-NR ' R "in which R 'and R" independently of each other have the meaning of hydrogen, aryl or C1-6 alkyl or R' and R "together with the N atom form a cycle. |
| priorityDate | 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.